Cellectar Biosciences logo

Cellectar Biosciences Share Price Today

(NASDAQ: CLRB)

Cellectar Biosciences share price is $0.3 & ₹26.09 as on 6 Mar 2025, 2.30 'hrs' IST

$0.3

0.02

(6.56%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cellectar Biosciences share price in Dollar and Rupees. Guide to invest in Cellectar Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cellectar Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Cellectar Biosciences share price movements

  • Today's Low: $0.29
    Today's High: $0.31

    Day's Volatility :7.11%

  • 52 Weeks Low: $0.22
    52 Weeks High: $4.34

    52 Weeks Volatility :94.84%

Cellectar Biosciences (CLRB) Returns

PeriodCellectar Biosciences IncIndex (Russel 2000)
3 Months
-79.04%
0.0%
6 Months
-86.43%
0.0%
1 Year
-92.87%
0.0%
3 Years
-93.74%
-11.6%

Cellectar Biosciences (CLRB) Key Statistics

in dollars & INR

Previous Close
$0.285
Open
$0.2861
Today's High
$0.308
Today's Low
$0.2861
Market Capitalization
$12.7M
Today's Volume
$101.2K
52 Week High
$4.34
52 Week Low
$0.224
Revenue TTM
$0.0
EBITDA
$-51.3M
Earnings Per Share (EPS)
$-1.41
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-474.63%

How to invest in Cellectar Biosciences Stock (CLRB) from India?

It is very easy for Indian residents to invest directly in Cellectar Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cellectar Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cellectar Biosciences or CLRB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cellectar Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cellectar Biosciences shares which would translate to 2.899 fractional shares of Cellectar Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cellectar Biosciences, in just a few clicks!

Returns in Cellectar Biosciences (CLRB) for Indian investors in Rupees

The Cellectar Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cellectar Biosciences investment value today

Current value as on today

₹12,463

Returns

₹87,537

(-87.54%)

Returns from Cellectar Biosciences Stock

₹92,500 (-92.5%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Cellectar Biosciences (CLRB)

-44%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cellectar Biosciences Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cellectar Biosciences

  • Vanguard Group Inc

    3.75%

  • ADAR1 Capital Management LLC

    1.27%

  • Squarepoint Ops LLC

    1.13%

  • UBS Group AG

    0.82%

  • Geode Capital Management, LLC

    0.76%

  • BlackRock Inc

    0.50%

Analyst Recommendation on Cellectar Biosciences

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cellectar Biosciences(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Cellectar Biosciences Stock (CLRB)

What analysts predicted

Upside of 1788.9%

Target:

$5.67

Current:

$0.30

Insights on Cellectar Biosciences Stock (Ticker Symbol: CLRB)

  • Price Movement

    In the last 1 month, CLRB stock has moved up by 8.9%
  • CLRB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 155.3%
  • CLRB vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 141.6%

Cellectar Biosciences Technicals Summary

Sell

Neutral

Buy

Cellectar Biosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cellectar Biosciences (CLRB) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cellectar Biosciences Inc logo
8.78%
-86.43%
-92.87%
-93.74%
-98.56%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cellectar Biosciences Inc logo
NA
NA
0.0
-1.57
-4.75
-1.1
NA
0.04
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cellectar Biosciences Inc logo
Buy
$12.7M
-98.56%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Cellectar Biosciences

Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.
Organization
Cellectar Biosciences
Employees
20
CEO
Mr. James V. Caruso
Industry
Health Technology

Management People of Cellectar Biosciences

NameTitle
Mr. James V. Caruso
President, CEO & Director
Mr. Chad J. Kolean CPA
VP, CFO & Secretary
Mr. Jarrod Longcor
Chief Operating Officer

Important FAQs about investing in CLRB Stock from India :

What is Cellectar Biosciences share price today?

Cellectar Biosciences share price today stands at $0.30, Open: $0.29 ; Previous Close: $0.28 ; High: $0.31 ; Low: $0.29 ; 52 Week High: $4.34 ; 52 Week Low: $0.22.

The stock opens at $0.29, after a previous close of $0.28. The stock reached a daily high of $0.31 and a low of $0.29, with a 52-week high of $4.34 and a 52-week low of $0.22.

Can Indians buy Cellectar Biosciences shares?

Yes, Indians can invest in the Cellectar Biosciences (CLRB) from India.

With INDmoney, you can buy Cellectar Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cellectar Biosciences at zero transaction cost.

How can I buy Cellectar Biosciences shares from India?

It is very easy to buy Cellectar Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cellectar Biosciences (CLRB) be purchased?

Yes, you can buy fractional shares of Cellectar Biosciences with INDmoney app.

What are the documents required to start investing in Cellectar Biosciences stocks?

To start investing in Cellectar Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cellectar Biosciences Stock (CLRB)?

Today’s highest price of Cellectar Biosciences (CLRB) is $0.31.

Today’s lowest price of Cellectar Biosciences (CLRB) is $0.29.

What is today's market capitalisation of Cellectar Biosciences?

Today's market capitalisation of Cellectar Biosciences CLRB is 12.7M

What is the 52 Week High and Low Range of Cellectar Biosciences Stock (CLRB)?

  • 52 Week High

    $4.34

  • 52 Week Low

    $0.22

What are the historical returns of Cellectar Biosciences (CLRB)?

  • 1 Month Returns

    8.78%

  • 3 Months Returns

    -86.43%

  • 1 Year Returns

    -92.87%

  • 5 Years Returns

    -98.56%

Who is the Chief Executive Officer (CEO) of Cellectar Biosciences ?

Mr. James V. Caruso is the current Chief Executive Officer (CEO) of Cellectar Biosciences.